CLASS II ONGOING Device recall · Reported 15 Oct 2025 · FDA Enforcement Report
ClariTEE Miniaturized TEE probe recalled by ImaCor
ImaCor is recalling ClariTEE Miniaturized TEE probe, distributed nationwide in the US. The recall was initiated on 29 Aug 2025 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-0038-2026
- FDA event ID
- 97505
- Recalling firm
- ImaCor, Jericho, NY
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 29 Aug 2025
- FDA classified
- 3 Oct 2025
- Reported
- 15 Oct 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Other Reasons
- Device type
- Imaging Equipment
Timeline
| 29 Aug 2025 | Recall initiated by company | |
| 3 Oct 2025 | Classified by FDA | +35 days |
| 15 Oct 2025 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Production assembly error resulting in the potential for reversed articulation, where moving the lever forward caused the probe tip to anteflex rather than retroflex, and vice versa.
Product as listed by the FDA
ClariTEE Miniaturized TEE probe. Model Number: CLT-010. Ultrasound miniaturized TEE probe for use with Mobile Ultrasound, ImaCor model ZHH.
Where it was distributed
US Nationwide distribution in the states of South Carolina, New Jersey, Pennsylvania, Florida, and Georgia.
Nationwide FloridaGeorgiaNew JerseyPennsylvaniaSouth Carolina
Questions about this recall
Why was it recalled?
Production assembly error resulting in the potential for reversed articulation, where moving the lever forward caused the probe tip to anteflex rather than retroflex, and vice versa.
Which lots are affected?
Model CLT-010; UDI-DI 00861589000108; Lot number: 20261209.
Where was it sold?
US Nationwide distribution in the states of South Carolina, New Jersey, Pennsylvania, Florida, and Georgia.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from ImaCor
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | ClariTEE Probe- Miniature transesophageal echo ultrasound recalled | ImaCor | Packaging Defects | 4 states |
Other Imaging Equipment recalls
All 2,350| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Trinias Opera Smart (C16s, F12s)/Opera Grand(C12s,C16s recalled | Shimadzu Corporation Medical Systems Division | Potency & Assay | Nationwide |
| Device | CLASS II | Xact mole marker for mammography recalled by Solstice | Solstice | Other | Nationwide |
| Device | CLASS I | Philips Lumify Diagnostic Ultrasound System recalled | Philips Ultrasound | Other | Nationwide |
| Device | CLASS II | Computed Tomography X-ray System recalled by Shanghai United Imaging | Shanghai United Imaging Healthcare | Device Malfunction | Nationwide |
| Device | CLASS II | Computed Tomography X-ray System recalled by Shanghai United Imaging | Shanghai United Imaging Healthcare | Device Malfunction | Nationwide |